{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:15:58Z","timestamp":1794356158983,"version":"4.9.0"},"reference-count":58,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:p>Eumycetoma and chromoblastomycosis are chronic, disfiguring fungal infections of the subcutaneous tissue that rarely resolve spontaneously. Most patients do not achieve sustained long-term benefits from available treatments; therefore, new therapeutic options are needed. We evaluated the efficacy of posaconazole, a new extended-spectrum triazole antifungal agent, in 12 patients with eumycetoma or chromoblastomycosis refractory to existing antifungal therapies. Posaconazole 800 mg\/d was given in divided doses for a maximum of 34 months. Complete or partial clinical response was considered a success; stable disease or failure was considered a nonsuccess. All 12 patients had proven infections refractory to standard therapy. Clinical success was reported for five of six patients with eumycetoma and five of six patients with chromoblastomycosis. Two patients were reported to have stable disease. As part of a treatment-use extension protocol, two patients with eumycetoma who initially had successful outcome were successfully retreated with posaconazole after a treatment hiatus of &gt; 10 months. Posaconazole was well tolerated during long-term administration (up to 1015 d). Posaconazole therapy resulted in successful outcome in most patients with eumycetoma or chromoblastomycosis refractory to standard therapies, suggesting that posaconazole may be an important treatment option for these diseases.<\/jats:p>","DOI":"10.1590\/s0036-46652005000600006","type":"journal-article","created":{"date-parts":[[2006,1,16]],"date-time":"2006-01-16T17:05:07Z","timestamp":1137431107000},"page":"339-346","source":"Crossref","is-referenced-by-count":137,"title":["Posaconazole treatment of refractory eumycetoma and chromoblastomycosis"],"prefix":"10.1590","volume":"47","author":[{"given":"Ricardo","family":"Negroni","sequence":"first","affiliation":[{"name":"Hospital F.J. Mu\u00f1iz, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Tob\u00f3n","sequence":"additional","affiliation":[{"name":"Corporaci\u00f3n para Investigaciones Biol\u00f3gicas, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Bustamante","sequence":"additional","affiliation":[{"name":"Hospital Nacional Cayetano Heredia, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida","family":"Shikanai-Yasuda","sequence":"additional","affiliation":[{"name":"USP, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernando","family":"Patino","sequence":"additional","affiliation":[{"name":"Schering-Plough, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Restrepo","sequence":"additional","affiliation":[{"name":"Corporaci\u00f3n para Investigaciones Biol\u00f3gicas, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/JCM.40.3.1031-1036.2002","article-title":"Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan","volume":"40","author":"AHMED A.","year":"2002","journal-title":"J. clin. Microbiol.","ISSN":"https:\/\/id.crossref.org\/issn\/0095-1137","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1473-3099(04)01131-4","article-title":"Mycetoma caused by Madurella mycetomatis: a neglected infectious burden","volume":"4","author":"AHMED A.O.","year":"2004","journal-title":"Lancet infect. Dis."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/13693780400011104","article-title":"Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with new triazole, posaconazole","volume":"43","author":"AL-ABDELY H.","year":"2005","journal-title":"Med. Mycol."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1439-0507.2004.00984.x","article-title":"Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents","volume":"47","author":"ANDRADE T.S.","year":"2004","journal-title":"Mycoses","ISSN":"https:\/\/id.crossref.org\/issn\/0933-7407","issn-type":"print"},{"key":"ref5","series-title":"Antifungal drug therapy: A complete guide for the practitioner","first-page":"43","author":"ARENAS R","year":"1990"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"ASCIOGLU S.","year":"2002","journal-title":"Clin. infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref7","first-page":"222","article-title":"Chromomycosis: a twenty-year analysis of histologically confirmed cases in Jamaica","volume":"41","author":"BANSAL A.S.","year":"1989","journal-title":"Trop. geogr. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0041-3232","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000239050","article-title":"Tropical mycoses","volume":"38","author":"BAYLES M.A.","year":"1992","journal-title":"Chemotherapy","ISSN":"https:\/\/id.crossref.org\/issn\/0009-3157","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1439-0507.2001.00613.x","article-title":"Chromoblastomycosis: clinical and mycologic experience of 51 cases","volume":"44","author":"BONIFAZ A.","year":"2001","journal-title":"Mycoses","ISSN":"https:\/\/id.crossref.org\/issn\/0933-7407","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-4362.1997.00085.x","article-title":"Treatment of chromoblastomycosis with itraconazole, cryosurgery, and a combination of both","volume":"36","author":"BONIFAZ A.","year":"1997","journal-title":"Int. J. Derm.","ISSN":"https:\/\/id.crossref.org\/issn\/0011-9059","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/clinids\/9.Supplement_1.S57","article-title":"A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis","volume":"9","author":"BORELLI D.","year":"1987","journal-title":"Rev. infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0162-0886","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.1469-0691.2003.00596.x","article-title":"Two cases of subcutaneous Scedosporium apiospermum infection treated with voriconazole","volume":"9","author":"BOSMA F.","year":"2003","journal-title":"Clin. Microbiol. Infect."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1590\/S0074-02761996000600026","article-title":"Chromoblastomycosis murine model and in vitro test to evaluate the sensitivity of Fonsecaea pedrosoi to ketoconazole, itraconazole and saperconazole","volume":"91","author":"CARDONA-CASTRO N.","year":"1996","journal-title":"Mem. Inst. Oswaldo Cruz","ISSN":"https:\/\/id.crossref.org\/issn\/0074-0276","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/AAC.45.7.2151-2153.2001","article-title":"In vitro activities of four novel triazoles against Scedosporium spp","volume":"45","author":"CARRILLO A.J.","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/S0036-46651997000300004","article-title":"\"In vitro\" susceptibility testing of Fonsecaea pedrosoi to antifungals","volume":"39","author":"DE BEDOUT C.","year":"1997","journal-title":"Rev. Inst. Med. trop. S. Paulo","ISSN":"https:\/\/id.crossref.org\/issn\/0036-4665","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/JCM.36.10.2950-2956.1998","article-title":"Comparison of \"in vitro\" activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts","volume":"36","author":"ESPINEL-INGROFF A.","year":"1998","journal-title":"J. clin. Microbiol.","ISSN":"https:\/\/id.crossref.org\/issn\/0095-1137","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4269\/ajtmh.1996.55.45","article-title":"Forty years of chromoblastomycosis in Madagascar: a review","volume":"55","author":"ESTERRE P.","year":"1996","journal-title":"Amer. J. trop. Med. Hyg.","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2133.1996.tb15658.x","article-title":"Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study","volume":"134","author":"ESTERRE P.","year":"1996","journal-title":"Brit. J. Derm."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1046\/j.1365-2133.2001.04511.x","article-title":"Eumycetoma due to Madurella mycetomatis acquired in Jamaica","volume":"145","author":"FLETCHER C.L.","year":"2001","journal-title":"Brit. J. Derm."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1128\/AAC.47.4.1436-1438.2003","article-title":"Activity of posaconazole against Pseudallescheria boydii: \"in vitro\" and \"in vivo\" assays","volume":"47","author":"GONZALEZ G.M.","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref21","first-page":"415","author":"GRAYBILL J.R.","year":"2004"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/mmy.40.5.529.534","article-title":"Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil","volume":"40","author":"GUPTA A.K.","year":"2002","journal-title":"Med. Mycol."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/02681219280000751","article-title":"Mycetoma","volume":"30","author":"HAY R.J.","year":"1992","journal-title":"J. med. vet. Mycol.","ISSN":"https:\/\/id.crossref.org\/issn\/0268-1218","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s10096-002-0828-8","article-title":"Acremonium strictum pulmonary infection in a leukemic patient successfully treated with posaconazole after failure of amphotericin B","volume":"21","author":"HERBRECHT R.","year":"2002","journal-title":"Europ. J. clin. Microbiol. infect. Dis."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0149-2918(03)80126-1","article-title":"Voriconazole","volume":"25","author":"JEU L.","year":"2003","journal-title":"Clin. Therap."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jac\/42.6.741","article-title":"\"In-vitro\" activity of voriconazole, itraconazole and amphotericin B against filamentous fungi","volume":"42","author":"JOHNSON E.M.","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1046\/j.1365-4362.2002.01383.x","article-title":"Mycetoma in Yemen: clinicoepidemiologic and histopathologic study","volume":"41","author":"KHATRI M.L.","year":"2002","journal-title":"Int. J. Derm.","ISSN":"https:\/\/id.crossref.org\/issn\/0011-9059","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1365-4362.1995.tb04404.x","article-title":"Successful treatment of chromoblastomycosis due to Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy","volume":"34","author":"KULLAVANIJAYA P.","year":"1995","journal-title":"Int. J. Derm.","ISSN":"https:\/\/id.crossref.org\/issn\/0011-9059","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1093\/clinids\/9.Supplement_1.S64","article-title":"Itraconazole for deep mycoses: preliminary experience in Mexico","volume":"9","author":"LAVALLE P.","year":"1987","journal-title":"Rev. infect. dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0162-0886","issn-type":"print"},{"key":"ref30","first-page":"256","author":"LEWIS J.S.","year":"2003"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1128\/JCM.42.3.1376-1378.2004","article-title":"Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazole","volume":"42","author":"LODGE B.A.","year":"2004","journal-title":"J. clin. Microbiol.","ISSN":"https:\/\/id.crossref.org\/issn\/0095-1137","issn-type":"print"},{"key":"ref32","series-title":"Mandell, Douglas, and Bennett's principles and practices of infectious diseases","first-page":"2702","volume-title":"Agents of mycetoma","author":"MAHGOUB E.S.","year":"2000","edition":"5"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/AAC.46.1.62-68.2002","article-title":"\"In vitro\" activities of new and conventional antifungal agents against clinical Scedosporium isolates","volume":"46","author":"MELETIADIS J.","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1086\/340522","article-title":"Treatment of Scedosporium apiospermum brain abscesses with posaconazole","volume":"34","author":"MELLINGHOFF I.K.","year":"2002","journal-title":"Clin. infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0733-8635(18)30593-X","article-title":"Chromoblastomycosis","volume":"7","author":"MILAM C.P.","year":"1989","journal-title":"Derm. Clin."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1067\/mjd.2001.112220","article-title":"Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil","volume":"44","author":"MINOTTO R.","year":"2001","journal-title":"J. Amer. Acad. Derm.","ISSN":"https:\/\/id.crossref.org\/issn\/0190-9622","issn-type":"print"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/004947550203200123","article-title":"A unique case of bladder mycetoma","volume":"32","author":"MORINO G.","year":"2002","journal-title":"Trop. Doctor"},{"key":"ref38","first-page":"387","article-title":"Itraconazole: pharmacokinetics and indications","volume":"24","author":"NEGRONI R.","year":"1993","journal-title":"Arch. med. Res.","ISSN":"https:\/\/id.crossref.org\/issn\/0188-0128","issn-type":"print"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1086\/380840","article-title":"Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera","volume":"38(3","author":"NEGRONI R.","year":"2004","journal-title":"Clin. infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0891-5520(02)00066-1","article-title":"Subcutaneous mycoses","volume":"17","author":"QUEIROZ-TELLES F.","year":"2003","journal-title":"Infect. Dis. Clin. N. Amer."},{"key":"ref41","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-4362.1992.tb04252.x","article-title":"Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi","volume":"31","author":"QUEIROZ-TELLES F.","year":"1992","journal-title":"Int. J. Derm.","ISSN":"https:\/\/id.crossref.org\/issn\/0011-9059","issn-type":"print"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/S0190-9622(08)81277-7","article-title":"Treatment of tropical mycoses","volume":"31","author":"RESTREPO A.","year":"1994","journal-title":"J. Amer. Acad. Derm.","ISSN":"https:\/\/id.crossref.org\/issn\/0190-9622","issn-type":"print"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1749-6632.1988.tb40448.x","article-title":"Treatment of chromoblastomycosis with itraconazole","volume":"544","author":"RESTREPO A.","year":"1988","journal-title":"Ann. N. Y. Acad. Sci.","ISSN":"https:\/\/id.crossref.org\/issn\/0077-8923","issn-type":"print"},{"key":"ref44","author":"SABATELLI F.J.","year":"2004"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1034\/j.1399-3062.2002.02008.x","article-title":"Breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high-risk allogeneic hematopoietic stem cell transplantation: scedosporiasis and recent advances in antifungal therapy","volume":"4","author":"SAFDAR A.","year":"2002","journal-title":"Transplant. infect. Dis."},{"key":"ref46","first-page":"20","author":"SANSONE A.","year":"2004"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/S0036-46651999000200013","article-title":"Eumycetoma by Madurella grisea: report of the first case observed in the southern Brazilian region","volume":"41","author":"SEVERO L.C.","year":"1999","journal-title":"Rev. Inst. Med. trop. S. Paulo","ISSN":"https:\/\/id.crossref.org\/issn\/0036-4665","issn-type":"print"},{"key":"ref48","first-page":"45","article-title":"Treatment of chromoblastomycosis due to Fonsecaea pedrosoi with low-dose terbinafine","volume":"66","author":"SEVIGNY G.M.","year":"2000","journal-title":"Cutis","ISSN":"https:\/\/id.crossref.org\/issn\/0011-4162","issn-type":"print"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00003226-200301000-00008","article-title":"Activity of voriconazole against corneal isolates of Scedosporium apiospermum","volume":"22","author":"SHAH K.B.","year":"2003","journal-title":"Cornea","ISSN":"https:\/\/id.crossref.org\/issn\/0277-3740","issn-type":"print"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00001432-200212000-00004","article-title":"Laboratory evaluation of new antifungal agents against rare and refractory mycoses","volume":"15","author":"SUTTON D.A.","year":"2002","journal-title":"Curr. Opin. infect. Dis."},{"key":"ref51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1439-0507.2000.00548.x","article-title":"A case of chromoblastomycosis effectively treated with terbinafine: Characteristics of chromoblastomycosis in the Kitasato region, Japan","volume":"43","author":"TANUMA H.","year":"2000","journal-title":"Mycoses","ISSN":"https:\/\/id.crossref.org\/issn\/0933-7407","issn-type":"print"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/375075","article-title":"Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy","volume":"36","author":"TOB\u00d3N A.M.","year":"2003","journal-title":"Clin. infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0924-8579(01)00363-6","article-title":"\"In vitro\" antifungal activity of posaconazole against various pathogenic fungi","volume":"18","author":"UCHIDA K.","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref54","first-page":"627","article-title":"Madura's foot: report of a case caused by Madurella mycetomatis","volume":"10","author":"VERDOLINI R.","year":"2000","journal-title":"Europ. J. Derm."},{"key":"ref55","series-title":"Mandell, Douglas, and Bennett's principles and practices of infectious diseases","first-page":"2699","volume-title":"Agents of chromomycosis","author":"WAGNER K.","year":"2000","edition":"5"},{"key":"ref56","first-page":"195","article-title":"Posaconazole for treatment of invasive aspergillosis in patients who are refractory to or intolerant of conventional therapy: an externally controlled blinded trial [abstract]","volume":"102","author":"WALSH T.","year":"2003","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ejps.2004.01.005","article-title":"Effect of posaconazole on cytochrome p450 enzymes: a randomized, open-label, two-way crossover study","volume":"21","author":"WEXLER D.","year":"2004","journal-title":"Europ. J. pharm. Sci."},{"key":"ref58","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0002-9343(02)01456-0","article-title":"Cases from the Osler Medical Service at Johns Hopkins University: Scedosporium apiospermum mycetoma of the lung","volume":"113","author":"ZAAS D.","year":"2002","journal-title":"Amer. J. Med."}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v47n6\/27191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T03:33:01Z","timestamp":1586662381000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652005000600006&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0036-46652005000600006"],"URL":"https:\/\/doi.org\/10.1590\/s0036-46652005000600006","relation":{},"ISSN":["0036-4665"],"issn-type":[{"value":"0036-4665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}